Table 4 Multivariable analyses of overall survival

 Age (≥60 years vs. <60 years)

0.74 (0.44–1.21)

0.24

0.92 (0.53–1.56)

0.76

 HR (positive vs. negative)

0.57 (0.32–1.06)

0.08

1.05 (0.52–2.42)

0.89

 HER2 (negative vs. positive)

0.87 (0.25–5.44)

0.85

1.08 (0.23–19.3)

0.94

 NLR (<3 vs. ≥3)

0.53 (0.30–0.95)

0.03

0.56 (0.32–1.01)

0.05

 Age (≥60 years vs. <60 years)

0.60 (0.35–1.01)

0.06

0.74 (0.41–1.30)

0.3

 HR (positive vs. negative)

0.54 (0.30–1.01)

0.06

1.60 (0.73–3.91)

0.25

 HER2 (negative vs. positive)

1.05 (0.30–6.69)

0.94

2.34 (0.45–43.1)

0.36

 ALC (≥1,500/μL vs. <1,500/μL)

0.72 (0.37–1.40)

0.33

0.57 (0.28–1.18)

0.13

 NLR (<3 vs. ≥3)

0.80 (0.42–1.56)

0.51

1.65 (0.61–4.63)

0.32

 LMR (≥5 vs. <5)

0.64 (0.35–1.18)

0.15

0.50 (0.27–0.94)

0.03

 PLR (<250 vs. ≥250)

0.63 (0.33–1.30)

0.2

0.50 (0.18–1.35)

0.17